Cited by 1,685Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Glutamate Receptor Dysfunction and Schizophrenia

Olney, John W.·1995·Archives of General Psychiatry

DOI 10.1001/archpsyc.1995.03950240016004

Open this paper in CoChat — free account

Abstract

In this article, we advance a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights N-methyl-D-aspartate receptor hypofunction as a key mechanism that can help explain major clinical and pathophysiological aspects of schizophrenia. The following fundamental features of schizophrenia are accommodated by this hypothesis: (1) the occurrence of structural brain changes during early development that have the potential for producing subsequent clinical manifestations of schizophrenia, (2) a quiescent period in infancy and adolescence before clinical manifestations are expressed, (3) onset in early adulthood of psychotic symptoms, (4) involvement of dopamine (D2) receptors in some cases but not others that would explain why some but not all patients are responsive to typical neuroleptic therapy, and (5) ongoing neurodegenerative changes and cognitive deterioration in some patients. We propose that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents (clozapine, olanzapine, fluperlapine), a better understanding of the N-methyl-D-aspartate receptor hypofunction mechanism and ways of preventing its neurodegenerative consequences in the rat brain may lead to improved pharmacotherapy in schizophrenia.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1995.03950240016004

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Ketamine—its pharmacology and therapeutic uses
white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474
CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA
Johnstone, E., Frith, C., Crow, T. J., Husband, J., & Kreel, L. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90890-4 · Cited by 1,253
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,250
Self-citation
Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic
Mednick, S. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260109013 · Cited by 1,203
Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia
Shenton, M. E., Kikinis, R., Jolesz, F. A., Pollak, S. D., LeMay, M. J., Wible, C. G., Hokama, H., Martin, J., Metcalf, D., Coleman, M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270905 · Cited by 1,179
The current status of the dopamine hypothesis of schizophrenia
Carlsson, A. C. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 959
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
Is schizophrenia a neurodevelopmental disorder?
Murray, R. M., & Lewis, S. W. (1988) · BMJ · doi:10.1136/bmj.296.6614.63 · Cited by 911
Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 891
Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage
Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
Duration of psychosis and outcome in first-episode schizophrenia
Loebel, A. D., Lieberman, J. A., Alvir, J. M., Mayerhoff, D. I., Geisler, S. H., & Szymanski, S. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1183 · Cited by 880
Prenatal developmental disturbances in the limbic allocortex in schizophrenics
Jakob, H., & Beckmann, H. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249090 · Cited by 875
NMDA Antagonist Neurotoxicity: Mechanism and Prevention
Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., & Sesma, M. A. (1991) · Science · doi:10.1126/science.1835799 · Cited by 841
Self-citation
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
An anatomy of schizophrenia?
Stevens, J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200020023003 · Cited by 719
Ketamine: an update on the first twenty-five years of clinical experience
Reich, D. L., & Silvay, G. (1989) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03011442 · Cited by 707
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
Kim, J. S., Kornhuber, H. H., Schmid‐Burgk, W., & Holzmüller, B. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90178-0 · Cited by 694
Thalamic Abnormalities in Schizophrenia Visualized Through Magnetic Resonance Image Averaging
Andreasen, N. C., Arndt, S. V., Swayze, V. W., Cizadlo, T., Flaum, M. A., OʼLeary, D. S., Ehrhardt, J. C., & Yuh, W. T. C. (1994) · Science · doi:10.1126/science.7939669 · Cited by 694
Postmortem Evidence of Structural Brain Changes in Schizophrenia
Brown, R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010038005 · Cited by 685
A neurohistological correlate of schizophrenia.
Kovelman, J. A., & Scheibel, A. B. (1984) · PubMed · Cited by 582
Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia
Weinberger, D. R. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780070013001 · Cited by 573
The Genetics of Schizophrenia: A Current, Genetic-epidemiologic Perspective
Kendler, K. S., & Diehl, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.261 · Cited by 568
Quantitative Cytoarchitectural Studies of the Cerebral Cortex of Schizophrenics
Benes, F. M. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010033004 · Cited by 503
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
Carlsson, A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.2.164 · Cited by 502
Cell loss in the hippocampus of schizophrenics
Falkai, P., & Bogerts, B. (1986) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00380943 · Cited by 487
Phencyclidine-induced psychosis
Rm, A., & Young, S. J. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.9.1081 · Cited by 478
Neurotoxicity ofN-methyl-d-aspartate is markedly enhanced in developing rat central nervous system
McDonald, J. W., Silverstein, F. S., & Johnston, M. V. (1988) · Brain Research · doi:10.1016/0006-8993(88)90306-x · Cited by 470
Myelination of Cortical-hippocampal Relays During Late Adolescence
Benes, F. M. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.4.585 · Cited by 448
Limbic pathology in schizophrenia: The entorhinal region—a morphometric study
Falkai, P., Bogerts, B., & Rozumek, M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90162-x · Cited by 438
Hippocampal Pathologic Findings in Schizophrenia
Jeste, D. V. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110061009 · Cited by 428
Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms
Andreasen, N. C., Olsen, S. A., Dennert, J. W., & Smith, M. R. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.297 · Cited by 426
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum
Schwarcz, R. M., Creese, I., Coyle, J. T., & Snyder, S. H. (1978) · Nature · doi:10.1038/271766a0 · Cited by 400
Cholinergic Hyperactivity and Negative Schizophrenic Symptoms
Tandon, R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080075010 · Cited by 354
Amelioration of negative symptoms in schizophrenia by glycine
Javitt, D. C., Zylberman, I., Zukin, S. R., Heresco‐Levy, U., & Lindenmayer, J. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 353
Negative Symptoms in Schizophrenia: Their Longitudinal Course and Prognostic Importance
Pogue‐Geile, M. F., & Harrow, M. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.427 · Cited by 346
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M. L., & Carlsson, A. C. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity
Ikonomidou, C., Mosinger, J., Salles, K., Labruyere, J., & Olney, J. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-08-02809.1989 · Cited by 332
Self-citation
Cerebral Ventricular Enlargement in Chronic Schizophrenia
Weinberger, D. R. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140013001 · Cited by 326
Excitatory amino acids and neuropsychiatrie disorders
Olney, J. W. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90072-3 · Cited by 321
Self-citation
The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans
Kristensen, J. D., Svensson, B. A., & Gordh, T. (1992) · Pain · doi:10.1016/0304-3959(92)90266-e · Cited by 304
Recent Advances in the Neuropathology of Schizophrenia
Bogerts, B. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.431 · Cited by 285
Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
Bolden, C., Cusack, B. M., & Richelson, E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11335-9 · Cited by 276
MODEL PSYCHOSES AND SCHIZOPHRENIA
Luby, E. D., Gottlieb, J. S., Cohen, B. D., Rosenbaum, G., & Domino, E. F. (1962) · American Journal of Psychiatry · doi:10.1176/ajp.119.1.61 · Cited by 268
A “Glutamatergic Hypothesis” of Schizophrenia
Deutsch, S. I., Mastropaolo, J. P., Schwartz, B. L., Rosse, R. B., & Morihisa, J. M. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198902000-00001 · Cited by 268
Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl-d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex
Fix, A. S., Horn, J. W., Wightman, K. A., Johnson, C. A., Long, G. G., Storts, R. W., Farber, N. B., Wozniak, D. F., & Olney, J. W. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1153 · Cited by 256
Self-citation
The Significance of Age of Onset for Schizophrenia
DeLisi, L. E. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.2.209 · Cited by 247
MK‐801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex
Sharp, F. R., Jasper, P., Hall, J., Noble‐Haeusslein, L. J., & Sagar, S. M. (1991) · Annals of Neurology · doi:10.1002/ana.410300609 · Cited by 235
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors
Monnet, F. P., Debonnel, G., Junien, J., & de Montigny, C. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90186-a · Cited by 233
Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
Maura, G., Giardi, A., & Raiteri, M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13418-6 · Cited by 230
Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?
Farber, N. B., Wozniak, D. F., Price, M. T., Labruyere, J., Huss, J. M., Peter, H. S., & Olney, J. W. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00046-1 · Cited by 220
Self-citation
Benzodiazepines in the treatment of schizophrenia: a review and reappraisal
Wolkowitz, O. M., & Pickar, D. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.714 · Cited by 219
Activation of dopamine receptors inhibits calcium-dependent glutamate release from cotico-striatal terminals in vitro
Rowlands, G. J., & Roberts, P. J. J. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90285-x · Cited by 189
Presynaptic dopaminergic modulation of cortical input to the striatum
Kornhuber, J., & Kornhuber, M. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90013-5 · Cited by 183
In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
Monnet, F. P., Debonnel, G., & de Montigny, C. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10951-8 · Cited by 176
Observations on the psychotomimetic effects of sernyl
Bakker, C. B., & Amini, F. B. (1961) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(61)80033-3 · Cited by 159
Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat
Lodge, D., & Anis, N. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90022-x · Cited by 158
Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain
Ikonomidou, C., PRICE, M. T., Ogilvie, J. M., Frierdich, G. E., Labruyere, J., Salles, K., & Olney, J. W. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-05-01693.1989 · Cited by 147
Self-citation
Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder
Pearlson, G. D., Garbacz, D. J., Breakey, W. R., Ahn, H. S., & DePaulo, J. R. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90133-1 · Cited by 145
Abnormal Reinnervation as a Basis for Schizophrenia: A Hypothesis
Stevens, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030070009 · Cited by 134
Phencyclidine, Dizocilpine, and Cerebrocortical Neurons
Allen, H. L., & Iversen, L. L. (1990) · Science · doi:10.1126/science.2403696 · Cited by 132
Comparison of Phencyclidine Hydrochloride (Sernyl) with Other Drugs
Cohen, B. D. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01710230063007 · Cited by 131
The Effect of 1-Arylcyclohexylamine (Sernyl) on Twelve Normal Volunteers
Davies, B., & Beech, H. R. (1960) · Journal of Mental Science · doi:10.1192/bjp.106.444.912 · Cited by 124
Muscarinic cholinergic hyperactivity in schizophrenia
Tandon, R., Shipley, J. E., Greden, J. F., Mann, N. A., Eisner, W. H., & Goodson, J. A. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90006-d · Cited by 120
Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction
Perry, T. L. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90212-9 · Cited by 110
Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine
Sharp, F. R., Butman, M., Wang, S., et al. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330413 · Cited by 107
Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity
Farber, N. B., Price, M. T., Labruyere, J., Nemnich, J., Peter, H. S., Wozniak, D. F., & Olney, J. W. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90265-f · Cited by 97
Self-citation
Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration
Ellison, G. D. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00070 · Cited by 94
Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex
Fix, A. S., Wozniak, D. F., Truex, L. L., McEwen, M. L., Miller, J. P., & Olney, J. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)00842-e · Cited by 94
Self-citation
Dissimilar patterns of degeneration in brain following four different addictive stimulants
Ellison, G. D., & Switzer, R. C. (1993) · Neuroreport · doi:10.1097/00001756-199310000-00004 · Cited by 92
Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels
Sharp, F. R., Butman, M., Koıstınaho, J., Aardalen, K., Näkki, R., Massa, S. M., Swanson, R. A., & Sagar, S. M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90345-x · Cited by 89
Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism
Hargreaves, R. J., Rigby, M., Smith, D. W., Hill, R. G., & Iversen, L. L. (1993) · Neurochemical Research · doi:10.1007/bf00975046 · Cited by 79
Phencyclidine poisoning in young children
Karp, H., Kaufman, N., & Anand, S. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80447-1 · Cited by 69
Observations on the Action of Sernyl — A New Psychotropic Drug
Ban, T. A., Lohrenz, J. J., & Lehmann, H. E. (1961) · Canadian Psychiatric Association Journal · doi:10.1177/070674376100600307 · Cited by 63
Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity.
Olney, J. W., & Farber, N. B. (1994) · PubMed · Cited by 62
Self-citation
Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
Maura, G., Carbone, R., & Raiteri, M. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21065-5 · Cited by 59
The PCP Psychosis: Prolonged Intoxication or Drug-Precipitated Functional Illness?
Erard, R. E., Luisada, P. V., & Peele, R. (1980) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1980.10471432 · Cited by 59
CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses
Altar, C. A., Wasley, A., Liebman, J. M., et al. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90017-2 · Cited by 54
PCP Intoxication in Young Children and Infants
Welch, M. J., & Correa, G. A. (1980) · Clinical Pediatrics · doi:10.1177/000992288001900801 · Cited by 50
Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms
Fayen, M., Goldman, M. B., Moulthrop, M. A., et al. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.4.483 · Cited by 48
Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?
Fisch, R. Z. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02757.x · Cited by 48
α2 Adrenergic Agonists Prevent MK-801 Neurotoxicity
Farber, N. B. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00048-i · Cited by 47
PCP (Phencyclidine): An Update
Garey, R. E. (1979) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1979.10471408 · Cited by 47
Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors.
Gué, M., Junien, J., Rio, C. D., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11154-3 · Cited by 38
Characterizing Anticholinergic Abuse in Community Mental Health
Wells, B. G., Marken, P. A., Rickman, L. A., et al. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198912000-00009 · Cited by 30
Neuropeptide Y and JO 1784, a selective σ ligand, alter intestinal ion transport through a common, haloperidol-sensitive site
Rivière, P. J.-M., Pascaud, X., Junien, J. L., et al. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90388-m · Cited by 30
Measles virus-induced hippocampal neurodegeneration in the mouse: A novel, subacute model for testing neuroprotective agents
Andersson, T., Schwarcz, R. M., Löve, A., et al. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90183-l · Cited by 28
Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry.
Fix, A. S., Wightman, K. A., & O'Callaghan, J. P. (1995) · PubMed · Cited by 26
Untoward Effects of Ketamine Combined with Diazepam for Supplementing Conduction Anaesthesia in Young and Middle‐Aged Adults
Korttila, K. T., & Levänen, J. (1978) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1978.tb01348.x · Cited by 26
Effect of thiopentone on emergence reactions to ketamine anaesthesia
MAGBAGBEOLA, J. A. O., & Thomas, N. A. (1974) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03005737 · Cited by 25
Heredity and Environment in Schizophrenia, Revisited
Stabenau, J. R., & Pollin, W. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199305000-00003 · Cited by 24
Glutamatergic, Cholinergic, and GABAergic Systems in Posterior Cingulate Cortex: Interactions and Possible Mechanisms of Limbic System Disease
Olney, J. W., Sesma, M. A., & Wozniak, D. F. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6704-6_20 · Cited by 20
Self-citation
[Clinical use of benzodiazepines].
Bratfos, O. (1977) · PubMed · Cited by 9
Die Technic der Hypnose
Mayer, L. (1935) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-193503000-00070 · Cited by 8
Dose-related effects of the NMDA antagonist, ketamine, in healthy humans
Krystal, J. H., Karper, L., Seibyl, J., et al. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90538-t · Cited by 8
Poly(A)+mRNA as a marker of metabolic activity in schizophrenia: Differential changes in parahippocampal gyrus and CA1
Eastwood, S. L., Falkai, P., Bogerts, B., et al. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)95180-h · Cited by 3

Sorted by citations

A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134

See all 1,685

Authors: Olney, J. W.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Olney, John W.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1995-12-01
Volume: 52
Issue: 12
Pages: 998
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1995.03950240016004
OpenAlex: W2093248761
Cited by: 1,685
References: 99
Citations by year: 2026: 20 · 2025: 13 · 2024: 17 · 2023: 23 · 2022: 35 · 2021: 37 · 2020: 44 · 2019: 49 · 2018: 37 · 2017: 49 · 2016: 51 · 2015: 52 · 2014: 53 · 2013: 54 · 2012: 62
FWCI: 45.32
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (1r01da006454-01)
National Institute on Drug Abuse (R01DA005072, DA07261, DA05072, T32DA007261, DA 06454)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: schizophrenia, NMDA receptor hypofunction, dopamine D2 receptor, psychosis, atypical antipsychotics, clozapine, olanzapine, neurodegeneration, brain development, cognitive decline
MeSH terms: Animals, Brain, Gyrus Cinguli, Microscopy, Electron, Models, Neurological, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Receptors, Glutamate, Pyramidal Cells, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glutamate Receptor Dysfunction and Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks